Raymond James Financial Services Advisors’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $567K | Sell |
23,028
-207
| -0.9% | -$5.1K | ﹤0.01% | 2525 |
|
|
2024
Q2 | $537K | Sell |
23,235
-925
| -4% | -$21.4K | ﹤0.01% | 2483 |
|
|
2024
Q1 | $582K | Sell |
24,160
-3,455
| -13% | -$83.2K | ﹤0.01% | 2398 |
|
|
2023
Q4 | $635K | Buy |
27,615
+4,138
| +18% | +$95.2K | ﹤0.01% | 2252 |
|
|
2023
Q3 | $478K | Sell |
23,477
-11,702
| -33% | -$238K | ﹤0.01% | 2354 |
|
|
2023
Q2 | $822K | Sell |
35,179
-471
| -1% | -$11K | ﹤0.01% | 2036 |
|
|
2023
Q1 | $830K | Buy |
35,650
+1,492
| +4% | +$34.7K | ﹤0.01% | 2022 |
|
|
2022
Q4 | $860K | Sell |
34,158
-2,508
| -7% | -$63.1K | ﹤0.01% | 1935 |
|
|
2022
Q3 | $968K | Buy |
36,666
+842
| +2% | +$22.2K | ﹤0.01% | 1829 |
|
|
2022
Q2 | $1.04M | Sell |
35,824
-20,171
| -36% | -$583K | ﹤0.01% | 1808 |
|
|
2022
Q1 | $1.93M | Buy |
55,995
+14,902
| +36% | +$513K | ﹤0.01% | 1515 |
|
|
2021
Q4 | $1.8M | Buy |
41,093
+30,006
| +271% | +$1.31M | ﹤0.01% | 1611 |
|
|
2021
Q3 | $562K | Buy |
11,087
+818
| +8% | +$41.5K | ﹤0.01% | 2292 |
|
|
2021
Q2 | $534K | Buy |
10,269
+510
| +5% | +$26.5K | ﹤0.01% | 2326 |
|
|
2021
Q1 | $446K | Buy |
+9,759
| New | +$446K | ﹤0.01% | 2364 |
|